Patent US5176996A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5176996A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use

Assignee: Baylor College of Medicine
•
Filing: 1989-12-22
•
Granted: 1993-01-05
•
Expires: 2009-12-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for making synthetic oligonucleotides which bind to target sequences in a duplex DNA forming colinear triplexes by binding to the major groove. The method includes scanning genomic duplex DNA and identifying nucleotide target sequences of greater than about 20 nucleotides having either about at least 65% purine bases or about at least 65% pyrimidine bases; and synthesizing synthetic oligonucleotides complementary to identified target sequences. The synthetic oligonucleotides have a G when the complementary location in the DNA duplex has a GC base pair and have a T when the complementary location in the DNA duplex has an AT base pair. The synthetic oligonucleotides are oriented 5' to 4' and bind parallel or 3' to 5' and bind anti-parallel to the about at least 65% purine strand.

Inventors

  • 👤 Michael E. Hogan
  • 👤 Donald J. Kessler

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 16:06
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/113; A; A61; A61K; A61K48/00; C07; C07H; C07H21/00; C07H21/04; C12N15/1137; C12N15/1138; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6839; C12Q1/6876; C12Q1/6883; C12Q1/6886; C12Q1/70; C12Q1/701; C12Q1/702; C12Q1/703; C12Q1/705; C12Q1/708; C12Y; C12Y101/00; C12Y101/01; C12Y101/01034; C12Y205/00; C12Y205/01; C12Y205/01018; C12Y207/00; C12Y207/07; C12Y207/07007; A61K38/00; C12N2310/00; C12N2310/10; C12N2310/15; C12N2310/30; C12N2310/32; C12N2310/321; Y; Y10; Y10T; Y10T436/00; Y10T436/14; Y10T436/142222; Y10T436/143333

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 127 words
A method of making a synthetic oligonucleotide which binds to a target sequence in duplex DNA forming a collinear triplex by binding to the major groove, said method comprising the steps of: (a) identifying a duplex nucleotide target sequence of greater than about 20 nucleotides on each strand, said target sequence having either about at least 65% purine bases or about at least 65% pyrimidine bases on each strand; and (b) synthesizing said synthetic olignucleotide complementary to said identified target sequence, said synthetic oligonucleotide including a G and a T, wherein said synthetic oligonucleotide has a G when the complementary location in the DNA duplex has a GC base pair and has a T when the complementary location in the DNA duplex has an AT base pair.
Claim 2
Independent Claim 127 words
A method of making a synthetic oligonucleotide which binds to a target sequence in duplex DNA forming a collinear triplex by binding to the major groove, said method comprising the steps of: (a) identifying a duplex nucleotide target sequence of greater than about 20 nucleotides on each strand, said target sequence having either about at least 65% purine bases or about at least 65% pyrimidine bases on each strand; and (b) synthesizing said synthetic olignucleotide complementary to said identified target sequence, said synthetic oligonucleotide including a G and a T, wherein said synthetic oligonucleotide has a G when the complementary location in the DNA duplex has a GC base pair and has a T when the complementary location in the DNA duplex has an AT base pair.
Claim 3
Dependent Claim 39 words
The method of claim 1 wherein said synthetic oligonucleotide is oriented 3' to 5' and binds anti-parallel to the about at least 65% purine strand, wherein the orienting strand of the duplex DNA is the more purine rich strand.
Claim 4
Dependent Claim 39 words
The method of claim 1, wherein said synthetic oligonucleotide is oriented 5' to 3' and binds parallel to the about at least 65% purine strand, wherein the orienting strand of the duplex DNA is the more purine rich strand.

References Cited (Backward Citations)

US4469863A Cited
US4511713A Cited
US4757055A Cited
US4667025A Cited
US4587044A Cited
US4740463A Cited
US4806463A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-01-05 1996-07-06 1997-01-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-01-05 2000-07-06 2001-01-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-01-05 2004-07-06 2005-01-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag